Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Otol Rhinol Laryngol ; 122(3): 210-5, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23577575

ABSTRACT

OBJECTIVES: We evaluated the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-2 (MMP-2) in nasopharyngeal carcinoma (NPC) and studied their relationship with cervical lymph node metastasis. METHODS: Immunohistochemical staining was used to detect the expression of EMMPRIN and MMP-2 in specimens from patients with chronic nasopharyngitis (CN), nonmetastastic NPC (NM-NPC), and lymph node-metastatic NPC (LNM-NPC). RESULTS: The rates of positive EMMPRIN expression in CN, NM-NPC, and LNM-NPC were 13.3%, 30.0%, and 66.7%, respectively. Significant differences were found between the rates in CN and LNM-NPC (p <0.01) and between the rates in NM-NPC and LNM-NPC (p = 0.01). In the LNM-NPC group, NPC cells had a higher rate of expression of EMMPRIN in tumor metastases than in the primary tumor (81.8% versus 66.7%; p = 0.01). The rates of positive MMP-2 expression in CN, NM-NPC, and LNM-NPC were 13.3%, 35.0%, and 60.6%, respectively. A significant difference was found between the rates in CN and LNM-NPC (p < 0.01). In the LNM-NPC group, NPC cells had a higher rate of MMP-2 expression in tumor metastases than in the primary tumor (72.7% versus 60.6%; p <0.01). The expressions of MMP-2 and EMMPRIN were highly correlated (rs = 0.466; p <0.01). CONCLUSIONS: Nasopharyngeal carcinoma cells may attain enhanced metastastic capability through the expression of MMP-2 induced by EMMPRIN.


Subject(s)
Basigin/metabolism , Carcinoma/enzymology , Lymph Nodes/pathology , Matrix Metalloproteinase 2/metabolism , Nasopharyngeal Neoplasms/enzymology , Nasopharyngeal Neoplasms/metabolism , Adult , Aged , Carcinoma/pathology , Carcinoma, Squamous Cell/enzymology , Carcinoma, Squamous Cell/pathology , Case-Control Studies , Female , Head and Neck Neoplasms/enzymology , Head and Neck Neoplasms/pathology , Humans , Immunohistochemistry , Lymphatic Metastasis , Male , Middle Aged , Nasopharyngeal Neoplasms/pathology , Nasopharyngitis/enzymology , Neck , Neoplasm Invasiveness , Squamous Cell Carcinoma of Head and Neck
2.
Head Neck ; 24(3): 223-7, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11891953

ABSTRACT

BACKGROUND: To assess the usefulness of combining cytodiagnosis and DNA cytometry on nasopharyngeal brush samples for the detection of nasopharyngeal carcinoma (NPC). METHODS: DNA ploidy analysis was undertaken on 66 nasopharyngeal brush samples that had been previously evaluated cytologically. RESULTS: Cytodiagnosis and ploidy analysis demonstrated a sensitivity of 66% and 55%, respectively. Both techniques had a specificity of 100% for NPC cases that were histologically confirmed. The negative predictive values for cytodiagnosis and ploidy analysis were 29% and 24%, respectively. CONCLUSIONS: The sensitivity and specificity for cytodiagnosis were not improved by the addition of DNA ploidy analysis. Furthermore, combining the two techniques did not confer any significant advantage compared with the use of cytology and DNA ploidy alone. The relatively low negative predictive values are a significant limitation, and combining cytodiagnosis and ploidy analysis on nasopharyngeal brush samples cannot be recommended for the detection of NPC.


Subject(s)
Carcinoma/diagnosis , Cytodiagnosis , DNA, Neoplasm/genetics , Nasopharyngeal Neoplasms/diagnosis , Adult , Aged , Aged, 80 and over , Biopsy , Female , Humans , Male , Middle Aged , Nasopharyngeal Neoplasms/pathology , Nasopharynx/pathology , Ploidies , Predictive Value of Tests , Sensitivity and Specificity , Specimen Handling
SELECTION OF CITATIONS
SEARCH DETAIL
...